Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
587 0 |
SM ISO690:2012 PANTEA, Valeriu, RUDIC, Valeriu, SPÂNU, Constantin, CEBOTARESCU, Valentin, COJUHARI, Lilia, JIMBEI, Paulina, DEATIŞEN, Victor. Tamiflu şi BioR în tratamentul pacienţilor cu gripă A (H1N1). In: Sănătate Publică, Economie şi Management în Medicină , 2012, nr. 5(44), pp. 83-86. ISSN 1729-8687. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Sănătate Publică, Economie şi Management în Medicină | |||
Numărul 5(44) / 2012 / ISSN 1729-8687 /ISSNe 2587-3873 | |||
|
|||
Pag. 83-86 | |||
Descarcă PDF | |||
Rezumat | |||
A comparative study of combined Tamiflu and BioR treatment was performed în 22 patients with H1N1 infl uenza (an experimental lot) and 17 patients (control lot) în which was administered Tamifl u only. The diagnosis of A (H1N1) influenza was confi rmed by PCR. The Tamifl u and BioR combined treatment, opposite the monotherapy with Tamifl u, contributed to the decreasing of clinical symptomatology length, the admission length of patients with A (H1N1) infl uenza and the decreasing of hospitalization length of patients with brochopneumonia. |
|||
Cuvinte-cheie A (H1N1) influenza, Tamiflu, BioR, treatment, грипп A (H1N1), Тамифлу, БиоР, лечение |
|||
|
DataCite XML Export
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'> <creators> <creator> <creatorName>Pantea, V.I.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Rudic, V.F.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Spânu, C.</creatorName> <affiliation>Centrul Naţional de Sanătate Publică, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Cebotarescu, V.T.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Cojuhari, L.B.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Jimbei, P.</creatorName> <affiliation>Spitalul Clinic Republican de Boli Infecţioase „Toma Ciorbă“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Deatişen, V.</creatorName> <affiliation>Spitalul Clinic Republican de Boli Infecţioase „Toma Ciorbă“, Moldova, Republica</affiliation> </creator> </creators> <titles> <title xml:lang='ro'>Tamiflu şi BioR în tratamentul pacienţilor cu gripă A (H1N1)</title> </titles> <publisher>Instrumentul Bibliometric National</publisher> <publicationYear>2012</publicationYear> <relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1729-8687</relatedIdentifier> <subjects> <subject>A (H1N1) influenza</subject> <subject>Tamiflu</subject> <subject>BioR</subject> <subject>treatment</subject> <subject>грипп A (H1N1)</subject> <subject>Тамифлу</subject> <subject>БиоР</subject> <subject>лечение</subject> </subjects> <dates> <date dateType='Issued'>2012-09-01</date> </dates> <resourceType resourceTypeGeneral='Text'>Journal article</resourceType> <descriptions> <description xml:lang='en' descriptionType='Abstract'><p>A comparative study of combined Tamiflu and BioR treatment was performed în 22 patients with H1N1 infl uenza (an experimental lot) and 17 patients (control lot) în which was administered Tamifl u only. The diagnosis of A (H1N1) influenza was confi rmed by PCR. The Tamifl u and BioR combined treatment, opposite the monotherapy with Tamifl u, contributed to the decreasing of clinical symptomatology length, the admission length of patients with A (H1N1) infl uenza and the decreasing of hospitalization length of patients with brochopneumonia.</p></description> <description xml:lang='ru' descriptionType='Abstract'><p>Под наблюдениием находились 22 больных с гриппом A (H1N1), экспериментальная группа, и 17 больных с тем же диагнозом, контрольная группа. В первой группе было назначено лечение Тамифлу и БиоР, а во второй группе – только Тамифлу. Диагноз гриппа A (H1N1) был подтвержден молекулярнобиологическим метотод (ПЦР). У больных, которые получали лечение Тамифлу и БиоР-ом (первая группа) длительность клинической симптоматики и пребывание в стационаре были в 2 раза меньше чем у больных второй группы, которые принимали только Тамифлу. Также уменьшилась длительность пребывания больных бронхопневмонией: в первой группе составила 5,2 дней, а во второй – 7 дней.</p></description> </descriptions> <formats> <format>application/pdf</format> </formats> </resource>